EPISODE · Apr 7, 2026 · 17 MIN
E212: The Ethics of AI
from AI For Pharma Growth · host Dr Andree Bates
AI ethics has moved from theory to urgent necessity, especially as AI systems become embedded in healthcare, business decisions, and society at large. In this episode, Dr Andree Bates is joined by Dr Nadia Morozova, founder of Enriched Insights, to unpack what ethical AI really means in practice, and how organisations can innovate quickly without creating risk, bias, or governance failures.Nadia shares insights from the global conversation on AI ethics, including discussions at Davos, and explains why trust is becoming the true competitive advantage. She argues that organisations should use AI to build stronger, more open relationships with customers and stakeholders, where technology acts as an enabler rather than the centrepiece.The conversation then gets practical. Nadia outlines a human-centric framework for high-quality AI outcomes, covering accurate sampling, futureproofing (because models are trained on the past), data connectivity across sources, and responsible blending of human and synthetic data. She warns that leadership teams often treat AI as “magic”, assuming tools will solve complex problems like data harmonisation without the hard work of ontology, governance, and expert oversight.A real-world example brings this to life: the Zillow case, where initial success collapsed as market dynamics shifted and the model failed to adapt in time, leading to huge losses. For Nadia, the lesson is clear: ethical responsibility is not a checkbox at launch, it requires ongoing monitoring, review, and culture change.Nadia closes with a strategic message for leaders: start with business goals and targeted use cases, involve data experts early, build governance upfront, and keep humans in the loop throughout the AI lifecycle. Done properly, ethical AI is not a constraint on innovation, it is how you protect long-term value and trust.Topics CoveredWhy AI ethics is now an urgent business and societal issueTrust, transparency, and accountability in AI deploymentHuman centricity as the foundation of high data qualityAccurate sampling and avoiding “biased reality” in modelsWhy futureproofing matters when algorithms learn from the pastData connectivity, governance, and the ontology problemResponsible blending of human and synthetic dataDangerous leadership assumptions about AI “magic”The Zillow case and what happens without ongoing oversightStrategy first: KPIs, targeted use cases, and right-sized modelsSkills gaps: technical roles, business acumen, and cross-functional teamsCulture change and post-deployment monitoringAbout the PodcastAI For Pharma Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr Andree Bates, created to help pharma, biotech and healthcare organisations understand how AI-based technologies can save time, grow brands, and improve company results.This show blends deep sector experience with practical conversations that demystify AI for biopharma leaders, from start-up biotech right through to Big Pharma. Each episode features experts building AI-powered tools that are driving real-world results across discovery, R&D, clinical trials, medical affairs, market access, regulatory, insights, sales, marketing, and more.Dr. Andree Bates LinkedIn | Facebook | X
Embed this episode
NOW PLAYING
E212: The Ethics of AI
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.